The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Foot fracture 7
SANDOSTATIN LAR DEPOT Full blood count increased 7
SANDOSTATIN LAR DEPOT Functional gastrointestinal disorder 7
SANDOSTATIN LAR DEPOT Gallbladder enlargement 7
SANDOSTATIN LAR DEPOT Gastric disorder 7
SANDOSTATIN LAR DEPOT Gastroenteritis viral 7
SANDOSTATIN LAR DEPOT Gingivitis 7
SANDOSTATIN LAR DEPOT Hepatic enzyme increased 7
SANDOSTATIN LAR DEPOT Hypovitaminosis 7
SANDOSTATIN LAR DEPOT Joint injury 7
SANDOSTATIN LAR DEPOT Ligament sprain 7
SANDOSTATIN LAR DEPOT Limb deformity 7
SANDOSTATIN LAR DEPOT Lymphoma 7
SANDOSTATIN LAR DEPOT Malabsorption from injection site 7
SANDOSTATIN LAR DEPOT Metastases to abdominal wall 7
SANDOSTATIN LAR DEPOT Metastases to breast 7
SANDOSTATIN LAR DEPOT Metastases to central nervous system 7
SANDOSTATIN LAR DEPOT Neoplasm recurrence 7
SANDOSTATIN LAR DEPOT Nerve compression 7
SANDOSTATIN LAR DEPOT Oral pain 7

Total Records: 2,045     Number of Pages: 103